Expert CA Rudramurthy BV suggests a bullish stance. He recommends buying on dips, especially in pharma stocks like Glenmark, ...

The European Commission (EC) has approved Biocon Biologics’ biosimilars referencing Amgen’s bone disease therapy denosumab.

The stock’s current performance reflects a positive investor response, with Biocon demonstrating promising financial results ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Prestige Estates Projects Ltd., Ashok Leyland Ltd., and Biocon Ltd. are three midcap stocks with 'buy' recommendations on ...

Bangalore: Biocon has announced the appointment of Ekta Agarwal as the Interim Company Secretary and Compliance Officer ...

On July 9, even when the 90-day pause of Liberation Day ended, Nifty Pharma jumped by over 101 points before correcting.

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

Biocon Biologics, a subsidiary of Biocon, has secured EU marketing authorisation for its Denosumab biosimilars Vevzuo and ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

Biocon Biologics Ltd received UK approval for Vevzuo and Evfraxy, biosimilars of Denosumab. Vevzuo is approved for ...

Biocon Biologics delivers 100 million insulin cartridges to Malaysia, commercializes biosimilars in key global markets with ...